Polymeric Drug Delivery of Platinum-Based Anticancer Agents

被引:112
作者
Haxton, Katherine J. [1 ,2 ]
Burt, Helen M. [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[2] Keele Univ, Sch Phys & Geog Sci, Keele ST5 5BG, Staffs, England
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
polymeric drug delivery systems; polymers; dendrimers; nanoparticles; biodegradable polymers; microparticles; macromolecular drug delivery; macromolecular prodrugs; micelle; PLGA-MPEG NANOPARTICLES; METAL COMPLEX MICELLE; ANTITUMOR-ACTIVITY; CLINICAL PHARMACOKINETICS; CISPLATIN DELIVERY; ESCHERICHIA-COLI; PROSTATE-CANCER; BLOCK-COPOLYMER; CELL-DIVISION; PHASE-I;
D O I
10.1002/jps.21611
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Platinum-based anticancer agents such as cisplatin and carboplatin are in widespread clinical use but associated with many side effects. Improving the delivery of cytotoxic platinum compounds may lead to reduced side effects and achieve greater efficacy at lower doses. Polymer-based therapeutics have been investigated as potential drug delivery vehicles for platinum-based drugs. Against a background of the chemistry and pharmacology of cytotoxic platinum compounds, this review discusses the formation and properties of platinum-polymer complexes, dendrimers, micelles, and microparticulates. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2299-2316, 2009
引用
收藏
页码:2299 / 2316
页数:18
相关论文
共 137 条
  • [1] Structural and mechanistic aspects of platinum anticancer agents
    Ahmad, Saeed
    Isab, Anvarhusein A.
    Ali, Saqib
    [J]. TRANSITION METAL CHEMISTRY, 2006, 31 (08) : 1003 - 1016
  • [2] Akbuga J, 1999, J MICROENCAPSUL, V16, P697
  • [3] Andrews PA, 2000, CANC DRUG DISC DEV, V7, P89
  • [4] Araki H, 1999, ARTIF ORGANS, V23, P161
  • [5] PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties
    Avgoustakis, K
    Beletsi, A
    Panagi, Z
    Klepetsanis, P
    Karydas, AG
    Ithakissios, DS
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) : 123 - 135
  • [6] Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates - effect on human ovarian carcinoma
    Avichezer, D
    Schechter, B
    Arnon, R
    [J]. REACTIVE & FUNCTIONAL POLYMERS, 1998, 36 (01) : 59 - 69
  • [7] Recent progress in dendrimer-based nanocarriers
    Bai, Shuhua
    Thomas, Chandan
    Rawat, Amit
    Ahsan, Fakhrul
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2006, 23 (06): : 437 - 495
  • [8] A water-soluble polyamide containing cis-dicarboxylato-chelated platinum(II)
    Bariyanga, J
    Johnson, MT
    Mmutlane, EM
    Neuse, EW
    [J]. JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS, 2005, 15 (03) : 335 - 340
  • [9] Three generations of α,γ-diaminobutyric acid modified poly(propyleneimine) dendrimers and their cisplatin-type platinum complexes
    Bellis, E.
    Hajba, L.
    Kovacs, B.
    Sandor, K.
    Kollar, L.
    Kokotos, G.
    [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2006, 69 (1-2): : 151 - 161
  • [10] Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs
    Bontha, Satya
    Kabanov, Alexander V.
    Bronich, Tatiana K.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) : 163 - 174